Tenax Therapeutics (TENX) Price to Sales (2010 - 2015)

Tenax Therapeutics has disclosed Price to Sales across 5 years of filings, most recently posting 168423.2 for Q2 2015.

• In Q2 2015, Price to Sales changed N/A year-over-year to 168423.2; the TTM figure through Jun 2016 stood at 116848.11 (up 1262.78% YoY), while the FY2015 annual figure was 149709.51, changed N/A from the prior year.
• Price to Sales came in at 168423.2 for Q2 2015 at Tenax Therapeutics, up from 4251.76 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 185897.96 in Q3 2011 to a low of 4251.76 in Q2 2013.
• Average Price to Sales over 4 years is 65238.6, with a median of 42317.52 recorded in 2011.
• The largest YoY upside for Price to Sales was 41.27% in 2012 against a maximum downside of 94.74% in 2012.
• Over 4 years, Price to Sales stood at 42317.52 in 2011, then slumped by 87.32% to 5366.9 in 2012, then fell by 20.78% to 4251.76 in 2013, then surged by 3861.26% to 168423.2 in 2015.
• Per Business Quant data, the three most recent Price to Sales figures were 168423.2 in Q2 2015, 4251.76 in Q2 2013, and 8279.31 in Q1 2013.